Page last updated: 2024-08-23

bisantrene and Hematologic Diseases

bisantrene has been researched along with Hematologic Diseases in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Baruchel, A; Deméocq, F; Guillot, T; Leblanc, T; Lemerle, S; Leverger, G; Nelken, B; Schaison, G; Vannier, JP1
Alberts, DS; Mackel, C; Meyskens, FL1

Other Studies

2 other study(ies) available for bisantrene and Hematologic Diseases

ArticleYear
Treatment of relapsed or refractory acute leukemia in childhood with bisantrene combined with high dose aracytine.
    Medical and pediatric oncology, 1994, Volume: 22, Issue:2

    Topics: Adolescent; Adult; Anthracenes; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytarabine; Follow-Up Studies; Heart Diseases; Hematologic Diseases; Humans; Infant; Kidney Diseases; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Recurrence; Remission Induction

1994
Phase II trial of bisantrene in patients with metastatic melanoma.
    Cancer treatment reports, 1986, Volume: 70, Issue:8

    Topics: Adult; Aged; Anthracenes; Antibiotics, Antineoplastic; Female; Hematologic Diseases; Humans; Male; Melanoma; Middle Aged; Neoplasm Metastasis

1986